PMID: 6988267Jan 1, 1980Paper

Effect of insulin treatment on prostacyclin in experimental diabetes

Diabetologia
H E HarrisonM Johnson

Abstract

Diabetic patients have a high susceptibility to microvascular complications, atherosclerosis and thrombosis. Platelet hyperreactivity possibly related to an imbalance in arachidonic acid metabolism may be involved. Aortic rings or renal cortex produced a potent inhibitor of platelet aggregation, identified as prostacyclin (PGI2). Release of PGI2 by tissues from streptozotocin -- diabetic rats (aorta: 0.07 +/ 0.1 ng/mg wet weight; renal cortex 0.004 +/- 0.001 ng/mg wet weight) was significantly depressed when compared with controls (aorta: 0.26 +/- 0.07 ng/mg wet weight; renal cortex: 0.009 +/- 0.001 ng/mg wet weight). Treatment of diabetic animals with insulin for 8 days restored PGI2 production to normal. The finding that PGI2 is depressed in the aorta and in the kidney, tissues which develop angiopathy, and that this is normalised by insulin, suggests that impaired PGI2 production, perhaps associated with platelet hyperreactivity may play a role in the vascular complications of diabetes.

References

Feb 10, 1979·Lancet·M JohnsonJ B Elder
Jul 24, 1978·Life Sciences·H E HarrisonM Johnson
Jun 1, 1978·Pharmacological Research Communications·A SzczeklikJ Mruk
May 1, 1978·Archives of Ophthalmology·S WaltmanB Becker
Dec 15, 1977·The New England Journal of Medicine·P V HalushkaJ A Colwell
Aug 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·M HambergB Samuelsson
Apr 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·R RossL Harker
Mar 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·M Hamberg, B Samuelsson

❮ Previous
Next ❯

Citations

Dec 15, 1985·Biochemical Pharmacology·D L Clark, S F Queener
Oct 14, 1983·European Journal of Pharmacology·S FunakawaY Tochino
Jan 14, 1992·European Journal of Pharmacology·H MasumuraY Abe
Feb 16, 1987·Life Sciences·I WakabayashiK Nagai
Jan 1, 1981·Prostaglandins·A Dembińska-KiećT Zelazny
Mar 1, 1983·Prostaglandins·Y C Kim, R G Brodows
Jan 1, 1985·Pharmacology & Therapeutics·A Kahán
Jan 1, 1981·Progress in Lipid Research·C N HensbyC T Dollery
Apr 7, 1998·Medicina clínica·J Ybarra, J C López-Talavera
Sep 1, 1987·The Proceedings of the Nutrition Society·J Betteridge
Jan 1, 1992·Clinical and Experimental Pharmacology & Physiology·W C HodgsonR G King
Feb 1, 1983·The British Journal of Ophthalmology·C R James, E Cotlier
Jan 1, 1983·Upsala Journal of Medical Sciences·U ErikssonT Tuvemo
Feb 1, 1986·Kidney International·P K JensenH H Parving
Apr 1, 1995·Prostaglandins, Leukotrienes, and Essential Fatty Acids·K Watanabe, E A Jaffe
Oct 1, 1993·Prostaglandins, Leukotrienes, and Essential Fatty Acids·S Hyslop, G De Nucci
Mar 1, 1984·Progress in Cardiovascular Diseases·N B Ruderman, C Haudenschild
Feb 1, 1983·Metabolism: Clinical and Experimental·P J VoisinP Drouin
May 1, 1990·Prostaglandins, Leukotrienes, and Essential Fatty Acids·T Mourits-AndersenJ Ditzel
Dec 1, 1980·Thrombosis Research·K A JørgensenJ Dyerberg
Oct 1, 1981·Thrombosis Research·H TakedaH Uzawa
Mar 1, 1981·The American Journal of Medicine·S M MauerD M Brown
Jan 1, 1985·Acta paediatrica Scandinavica·U Ewald, T Tuvemo
May 1, 1987·Clinical and Experimental Pharmacology & Physiology·A L BouraR G King
Nov 1, 1986·British Journal of Pharmacology·A L BouraR G King
Feb 1, 1982·Prostaglandins, Leukotrienes, and Medicine·C W KarpenR V Panganamala
Jul 27, 2001·Diabetes Care·A I VinikG L Pittenger
Nov 30, 1983·The American Journal of Medicine·J A ColwellP V Halushka
Jun 9, 2017·Clinical Science·Erik WesteinAnna C Calkin
Oct 3, 2018·International Journal of Molecular Sciences·Albino CarrizzoCarmine Vecchione
Nov 24, 1999·The American Journal of Physiology·A C PfluegerF G Knox
Oct 1, 1985·The American Journal of Physiology·T O MyersM E Gerritsen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.